Mechanisms underlying the nociceptive and inflammatory responses induced by trypsin in the mouse paw.
It has been demonstrated that trypsin is able to evoke the classical signals of inflammation, mainly via the activation of proteinase-activated receptor-2 (PAR-2). This study was designed to evaluate the inflammatory and nociceptive responses caused by trypsin injection in the mouse paw. Trypsin produced a dose- and time-related paw edema, a response that was markedly reduced in PAR-2-deficient mice compared to wild-type mice, particularly at the early time-points after trypsin injection. In addition, trypsin produced an increase in myeloperoxidase (MPO) activity, which was significantly reduced in PAR-2-deficient mice. The injection of trypsin into the mouse paw also elicited a dose- and time-dependent spontaneous nociception, as well as thermal and mechanical hypernociceptive responses, which were consistently decreased in mice with genetic deletion of PAR-2. Pharmacological evaluation revealed that edema formation and spontaneous nociception caused by trypsin injection in the mouse paw are mediated by a complex range of mediators. Both edema and nociception seem to rely on the production of neuropeptides, probably involving C-fibre activation and vanilloid receptor-1 (TRPV1), besides the stimulation of kinin B(2) receptors. Edematogenic response is also likely related to the production of cyclooxygenase (COX) metabolites, whereas the mast cell activation appears to be greatly associated to spontaneous nociception. Altogether, the present results indicate that trypsin-induced edema and nociception in the mouse paw represent multi-mediated responses that are largely, but not exclusively, related to the activation of PAR-2. These pieces of evidence provide new insights on the role of trypsin in pain and inflammation.
Paszcuk
Ana Flávia
AF
Department of Pharmacology, Centre of Biological Sciences, Universidade Federal de Santa Catarina UFSC, Campus Universitário, Trindade, 88049-900, Florianópolis, SC, Brazil.
Quintão
Nara L M
NL
Fernandes
Elizabeth S
ES
Juliano
Luiz
L
Chapman
Kevin
K
Andrade-Gordon
Patricia
P
Campos
Maria Martha
MM
Vergnolle
Nathalie
N
Calixto
João B
JB
D000818:Animals; D004305:Dose-Response Relationship, Drug; D004487:Edema / Q000139:chemically induced; D007249:Inflammation / Q000139:chemically induced*; D008297:Male; D008407:Mast Cells / Q000502:physiology; D051379:Mice; D009619:Nociceptors / Q000187:drug effects* / Q000502:physiology; D010146:Pain / Q000503:physiopathology*; D043782:Receptor, Bradykinin B2 / Q000502:physiology; D044464:Receptor, PAR-2 / Q000502:physiology; D050916:TRPV Cation Channels / Q000502:physiology; D014357:Trypsin / Q000494:pharmacology*
D043782:Receptor, Bradykinin B2; D044464:Receptor, PAR-2; D050916:TRPV Cation Channels; C493921:TRPV1 protein, mouse; D014357:Trypsin